China CAS:1778-02-5 Manufacturer

Sticking to the principle of "Super Good quality, Satisfactory service" ,We are striving to become an excellent organization partner of you for CAS:1778-02-5,Pregnenolone, Our goal is always to enable clients comprehend their plans. We have been creating good endeavours to accomplish this win-win scenario and sincerely welcome you to join us.
CAS:1778-02-5, We severely promise that we give all the customers with the best quality products and solutions, the most competitive prices and the most prompt delivery. We hope to win a resplendent future for customers and ourselves.

Hot Products

  • Medroxyprogesterone Acetate

    Medroxyprogesterone Acetate

    Medroxyprogesterone Acetate has USP、EP、 IP、JP and KP. DMF, GMP is available.

    CAS:71-58-9

  • Fluticasone Propionate

    Fluticasone Propionate

    Fluticasone propionate has CP, EP and USP specifications. DMF available.

    CAS:80474-14-2

  • 16alpha-Hydroxyprednisolone

    16alpha-Hydroxyprednisolone

    16alpha-Hydroxyprednisolone has DMF available.

    CAS:13951-70-7

  • Mono-acetyl Ganciclovir

    Mono-acetyl Ganciclovir

    Mono-acetyl Ganciclovir Specification: Min 97.0%

    CAS:88110-89-8

  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

  • N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide

    N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide

    N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide is an intermediate of Dutasteride.

    CAS:98319-24-5

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept